Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-08-006690
Filing Date
2008-11-14
Accepted
2008-11-14 15:16:11
Documents
1
Period of Report
2008-11-13

Document Format Files

Seq Description Document Type Size
1 c55680_ex.html 4  
1 c55680_ex.xml 4 2887
  Complete submission text file 0000930413-08-006690.txt   5020
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ILEX ONCOLOGY INC 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229-2263
Business Address 2109438200
MICATI VICTOR P (Reporting) CIK: 0001236643 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 081190546